Guidance, NICE advice and quality standards In development
Showing 1 to 4 of 4
| Title | Type | Expected publication date |
|---|---|---|
| Fruquintinib for previously treated metastatic colorectal cancer ID6274 | Technology appraisal guidance | |
| Pembrolizumab with lenvatinib for previously treated metastatic colorectal cancer [ID5112] | Technology appraisal guidance | TBC |
| Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatments [ID6298] | Technology appraisal guidance | |
| Tucatinib with trastuzumab for previously treated HER2-positive colorectal cancer [ID6227] | Technology appraisal guidance |